Glaucoma clinical trial design: A review of the literature

por Stewart, William C., Stewart, Jeanette A., Nelson, Lindsay A.
Publicado 2014

The use of dorzolamide versus other hypotensive agents to prevent glaucomatous progression

por Diafas, Savvas, G Day, Douglas, Stewart, Jeanette A, Stewart, William C
Publicado 2007

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension

por Godfrey, David A, Peplinski, Lee S, Stewart, Jeanette A, Stewart, William C
Publicado 2009

Efficacy, safety, and improved tolerability of travoprost BAK-free ophthalmic solution compared with prior prostaglandin therapy

por Henry, J Charles, Peace, James H, Stewart, Jeanette A, Stewart, William C
Publicado 2008

Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients

por Miyashiro, Michael J, Lo, Samuel C, Stewart, Jeanette A, Stewart, William C
Publicado 2010

Single-versus double-masking in glaucoma clinical trials

por DeMill, D. L., Wirostko, Barbara M., Nelson, Lindsay A., Stewart, Jeanette A., Stewart, William C.
Publicado 2016

A new measure of patient satisfaction with ocular hypotensive medications: The Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)

por Atkinson, Mark J, Stewart, William C, Fain, Joel M, Stewart, Jeanette A, Dhawan, Ravinder, Mozaffari, Essy, Lohs, Jan
Publicado 2003

Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy

por Pfeiffer, Norbert, Scherzer, Maria-Luise, Maier, Hubert, Schoelzel, Sonja, Jasek, Mark C, Stewart, Jeanette A, Stewart, William C
Publicado 2010